Table 2—

Prevalence of serial decline at 6 months in idiopathic pulmonary fibrosis(IPF) and non-specific interstitial pneumonia (NSIP) patients

IPFNSIPp-value
Subjects n8472
DL,CO
 Significant decline >15%23 (27)13 (18)0.13
 Marginal decline 7.5–15%23 (27)4 (6)<0.001
 Marginal or significant decline >7.5%46 (55)17 (24)<0.001
FVC
 Significant decline >10%22 (26)13 (18)0.19
 Marginal decline 5–10%19 (23)7 (10)0.06
 Marginal or significant decline >5%41 (49)20 (28)<0.01
  • Data are presented as n (%), unless otherwise stated. A higher proportion of patients with IPF had either significant or marginal decline compared with those with NSIP (p<0.001). DL,CO: diffusing capacity of the lung for carbon monoxide; FVC: forced vital capacity.